We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
AUM
$19B
AUM Growth
+$1.28B
Cap. Flow
+$1.55B
Cap. Flow %
8.12%
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180

Top Buys

Rank Stock Value
1
ELAN icon
Elanco Animal Health
ELAN
+$89.1M
2
WEX icon
WEX
WEX
+$78.4M
3
BLK icon
Blackrock
BLK
+$73.2M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$71.9M
5
OMF icon
OneMain Financial
OMF
+$45.3M

Sector Composition

Rank Sector Weight
1 Technology 20.39%
2 Financials 14.65%
3 Healthcare 12.11%
4 Consumer Discretionary 7.54%
5 Industrials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQB icon
2951
AquaBounty Technologies
AQB
$6.02M
$8K ﹤0.01%
106
+51
+93% +$4.78K
ARCT icon
2952
Arcturus Therapeutics
ARCT
$211M
$8K ﹤0.01%
177
-15
-8% -$672
AXGN icon
2953
Axogen
AXGN
$2.5B
$8K ﹤0.01%
518
AZTA icon
2954
Azenta
AZTA
$1.48B
$8K ﹤0.01%
86
-125
-59% -$11.2K
BHV icon
2955
BlackRock Virginia Muni Bond Trust
BHV
$20.3M
$8K ﹤0.01%
505
CAN
2956
Canaan Creative
CAN
$159M
$8K ﹤0.01%
1,427
-1,627
-53% -$12.6K
CANG
2957
Cango Inc
CANG
$68.5M
$8K ﹤0.01%
200
CLVT icon
2958
Clarivate
CLVT
$1.16B
$8K ﹤0.01%
420
CRTO icon
2959
Criteo S.A. Ordinary Shares
CRTO
$923M
$8K ﹤0.01%
241
-64
-21% -$2.46K
CRVS icon
2960
Corvus Pharmaceuticals
CRVS
$1.17B
$8K ﹤0.01%
1,750
-750
-30% -$2.22K
CSIQ icon
2961
Canadian Solar
CSIQ
$1.08B
$8K ﹤0.01%
237
-4,703
-95% -$179K
CUZ icon
2962
Cousins Properties
CUZ
$4.88B
$8K ﹤0.01%
225
-55
-20% -$2.12K
E icon
2963
ENI
E
$77.5B
$8K ﹤0.01%
358
+29
+9% +$707
EVN
2964
Eaton Vance Municipal Income Trust
EVN
$426M
$8K ﹤0.01%
650
FBND icon
2965
Fidelity Total Bond ETF
FBND
$27.3B
$8K ﹤0.01%
+159
New +$8.53K
FCA icon
2966
First Trust China AlphaDEX Fund
FCA
$33.3M
$8K ﹤0.01%
280
-15,961
-98% -$492K
FDMO icon
2967
Fidelity Momentum Factor ETF
FDMO
$929M
$8K ﹤0.01%
+168
New +$8.43K
FNB icon
2968
FNB Corp
FNB
$6.75B
$8K ﹤0.01%
757
FOUR icon
2969
Shift4
FOUR
$3.26B
$8K ﹤0.01%
105
FR icon
2970
First Industrial Realty Trust
FR
$8.44B
$8K ﹤0.01%
160
+1
+0.6% +$54
FTXO icon
2971
First Trust Nasdaq Bank ETF
FTXO
$315M
$8K ﹤0.01%
252
+1
+0.4% +$31
HL icon
2972
Hecla Mining
HL
$11.3B
$8K ﹤0.01%
1,693
IOVA icon
2973
Iovance Biotherapeutics
IOVA
$2.87B
$8K ﹤0.01%
350
-150
-30% -$3.53K
JBGS
2974
JBG SMITH
JBGS
$708M
$8K ﹤0.01%
290
+235
+427% +$7.25K
KN icon
2975
Knowles
KN
$3.34B
$8K ﹤0.01%
438

Similar funds

Rockefeller Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.

  • Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
  • Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
  • Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
  • Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
  • Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
  • Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
  • Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.

Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.